• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫平滑肌瘤的发病率。

The frequency of uterine leiomyomas.

作者信息

Cramer S F, Patel A

机构信息

Department of Pathology, Rochester General Hospital, University of Rochester School of Medicine, New York 14621.

出版信息

Am J Clin Pathol. 1990 Oct;94(4):435-8. doi: 10.1093/ajcp/94.4.435.

DOI:10.1093/ajcp/94.4.435
PMID:2220671
Abstract

As a leading cause of hysterectomy in premenopausal women. uterine leiomyomas are a major public health problem. However, very little work has been done on their epidemiology. Indeed, their true frequency has never been established using systematic and meticulous methods. In this study, gross serial sectioning at 2-mm intervals was applied as an adjunct to routine pathology processing in 100 consecutive total hysterectomy specimens. This tripled the number of leiomyomas noted in routine pathology reports. There were 649 leiomyomas in 77 of 100 uteri, with multiplicity of leiomyomas in 84%. Although leiomyomas were more numerous and larger in women with a clinical diagnosis of myomatous uterus, the incidence was no higher than in uteri removed for other reasons. The postmenopausal incidence of leiomyomas was no lower than the premenopausal incidence, although postmenopausal leiomyomas were smaller and fewer. These findings suggest that epidemiologic studies of leiomyomas may not be valid if they are based only on clinical diagnoses or routine pathology reports.

摘要

子宫平滑肌瘤是绝经前女性子宫切除的主要原因,是一个重大的公共卫生问题。然而,关于其流行病学的研究却很少。事实上,从未使用系统且细致的方法确定过其真实发病率。在本研究中,对100例连续的全子宫切除标本在常规病理处理的基础上每隔2毫米进行大体连续切片。这使得常规病理报告中记录的平滑肌瘤数量增加了两倍。100例子宫中的77例有649个平滑肌瘤,84%为多发性平滑肌瘤。尽管临床诊断为子宫肌瘤的女性体内平滑肌瘤数量更多、体积更大,但发病率并不高于因其他原因切除的子宫。绝经后平滑肌瘤的发病率并不低于绝经前,尽管绝经后平滑肌瘤体积更小、数量更少。这些发现表明,如果仅基于临床诊断或常规病理报告进行平滑肌瘤的流行病学研究,可能并不准确。

相似文献

1
The frequency of uterine leiomyomas.子宫平滑肌瘤的发病率。
Am J Clin Pathol. 1990 Oct;94(4):435-8. doi: 10.1093/ajcp/94.4.435.
2
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.子宫平滑肌瘤。诊断时严重程度、症状及年龄方面的种族差异。
J Reprod Med. 1996 Jul;41(7):483-90.
3
Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance.子宫腺肌病、子宫肌瘤及其合并存在情况患病率的组织学评估。
Minerva Ginecol. 2019 Jun;71(3):177-181. doi: 10.23736/S0026-4784.18.04291-0. Epub 2018 Nov 27.
4
[Corpus carcinoma and myomatous uterus. Incidence and course during the last 25 years].
Fortschr Med. 1978 Mar 23;96(11):600-2.
5
Adenomyosis uteri: a study of 416 cases.
Aust N Z J Obstet Gynaecol. 1988 Feb;28(1):72-3. doi: 10.1111/j.1479-828x.1988.tb01615.x.
6
The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis?子宫平滑肌瘤的非随机区域分布:组织发生的线索?
Hum Pathol. 1992 Jun;23(6):635-8. doi: 10.1016/0046-8177(92)90318-w.
7
Significance of postmenopausal uterine leiomyomas: Focus on variants.绝经后子宫平滑肌瘤的意义:关注变异型。
J Obstet Gynaecol Res. 2018 Aug;44(8):1445-1450. doi: 10.1111/jog.13675. Epub 2018 May 29.
8
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.缺氧调节的血管生成因子肾上腺髓质素的表达与子宫平滑肌瘤血管密度相关。
Clin Cancer Res. 2000 Jul;6(7):2808-14.
9
Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal.大型无症状子宫平滑肌瘤的常规子宫切除术:重新评估
Obstet Gynecol. 1992 Apr;79(4):481-4.
10
Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.绝经后子宫肌瘤中孕激素受体变性和表达减少的可能意义。
BMC Womens Health. 2022 Aug 16;22(1):346. doi: 10.1186/s12905-022-01924-6.

引用本文的文献

1
Regulatory Role for Tumor Suppressor REST on Estrogen Receptor () Expression and Leiomyoma Pathophysiology.肿瘤抑制因子REST对雌激素受体()表达和平滑肌瘤病理生理学的调节作用。 (注:原文括号处内容缺失,翻译时保留原样)
bioRxiv. 2025 Aug 31:2025.08.29.673140. doi: 10.1101/2025.08.29.673140.
2
Narrative Review of Chronic Inflammation in Uterine Myoma: Lack of Specialized Pro-Resolving Lipid Mediators (SPMs) and Vitamin D as a Potential Reason for the Development of Uterine Fibroids.子宫肌瘤中慢性炎症的叙述性综述:缺乏专门的促消退脂质介质(SPMs)和维生素D作为子宫肌瘤发生的潜在原因
Biomedicines. 2025 Jul 26;13(8):1832. doi: 10.3390/biomedicines13081832.
3
Assessing blood flow in uterine fibroids using intravoxel incoherent motion imaging compared with dynamic contrast-enhanced MRI.
与动态对比增强磁共振成像相比,使用体素内不相干运动成像评估子宫肌瘤中的血流情况。
Sci Rep. 2025 Jan 23;15(1):2980. doi: 10.1038/s41598-024-83739-z.
4
Constructing a multi-ancestry polygenic risk score for uterine fibroids using publicly available data highlights need for inclusive genetic research.利用公开可用数据构建子宫肌瘤的多血统多基因风险评分凸显了包容性基因研究的必要性。
Pac Symp Biocomput. 2025;30:268-280. doi: 10.1142/9789819807024_0020.
5
Establishment of 3D Cultures of Myometrium, Leiomyoma, and Leiomyosarcoma Cells: Advantages and Disadvantages of Two Different Models.子宫肌层、平滑肌瘤和平滑肌肉瘤细胞三维培养的建立:两种不同模型的优缺点
Reprod Sci. 2024 Dec;31(12):3729-3742. doi: 10.1007/s43032-024-01724-3. Epub 2024 Nov 5.
6
Estrogen receptor alpha mediated repression of PRICKLE1 destabilizes REST and promotes uterine fibroid pathogenesis.雌激素受体α介导的PRICKLE1抑制作用使REST不稳定并促进子宫肌瘤发病机制。
bioRxiv. 2024 Sep 9:2024.09.09.612036. doi: 10.1101/2024.09.09.612036.
7
Causal relationship between genetically predicted uterine leiomyoma and cancer risk: a two-sample Mendelian randomization.基于遗传预测的子宫肌瘤与癌症风险之间的因果关系:两样本孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1429165. doi: 10.3389/fendo.2024.1429165. eCollection 2024.
8
Association between various cathepsins and uterine leiomyoma: A Mendelian randomization analysis.各种组织蛋白酶与子宫肌瘤的关联:一项孟德尔随机化分析。
PLoS One. 2024 Sep 12;19(9):e0310292. doi: 10.1371/journal.pone.0310292. eCollection 2024.
9
Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids.鉴定子宫肌瘤中的 m6A 修饰物和 RNA 修饰物。
Endocrinology. 2024 Jul 1;165(8). doi: 10.1210/endocr/bqae074.
10
Molecular Imaging in Gynecology: Beyond Cancer.妇产科分子影像学:超越癌症。
J Nucl Med. 2024 Jul 1;65(7):998-1003. doi: 10.2967/jnumed.124.267546.